Related Experiment Video
Updated: Jun 2, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Epidemiology of liver failure
Philippe Ichai1, Didier Samuel
1Centre Hépato-Biliaire, hôpital Paul-Brousse, AP-HP, 94800 Villejuif, France.
Summary
Paracetamol overdose is now the leading cause of fulminant hepatitis, surpassing viral infections. Identifying the cause is crucial for treating acute liver failure and determining transplant eligibility.
Area of Science:
- Hepatology
- Toxicology
- Infectious Diseases
Background:
- Fulminant hepatitis etiology varies globally and temporally.
- Key causes include viruses, paracetamol, other drugs, poisons, and undetermined origins.
- Etiological prevalence shifts geographically and over time.
Purpose of the Study:
- To analyze the changing landscape of fulminant hepatitis causes.
- To highlight the increasing role of paracetamol as an etiological agent.
- To underscore the importance of etiological diagnosis in acute liver failure management.
Main Methods:
- Review of epidemiological data on fulminant hepatitis etiology.
- Comparative analysis of etiological prevalence over the past decade.
- Assessment of diagnostic significance in clinical management.
Main Results:
- Paracetamol has emerged as the primary cause of fulminant hepatitis.
- Hepatitis B virus, once dominant, is now secondary to paracetamol.
- A significant percentage (15-30%) of cases remain of undetermined origin.
Conclusions:
- Etiological diagnosis is critical for targeted therapy in acute liver failure.
- Identifying the cause of fulminant hepatitis informs management decisions, including liver transplantation.
- The shift in etiology necessitates updated clinical guidelines and public health awareness.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...